Ready to Scale, Ready to Fund - Session 1: What investors really want to hear
Ready to Scale, Ready to Fund is a four-session program for founders and teams building medical biotech, medtech and digital health companies. The series brings together practical pitch coaching, go-to-market and IP strategy, venture capital insights, corporate venturing and alternative financing options.
Across the four sessions, participants will strengthen how they present their company, connect scientific or technological innovation to a credible market pathway, and make more informed funding choices. The program is designed around the different development journeys of biotech and healthtech companies, while focusing on the questions investors and strategic partners consistently ask.
Session 1 – Tell your story: what investors really want to hear
A strong pitch makes complex innovation understandable without oversimplifying it. This session helps biotech and healthtech founders explain the problem, the solution, the evidence and the opportunity in a way that is credible for investors. Attention will be given to the different proof points expected from therapeutic and platform biotech companies, medical device and diagnostic ventures, and digital health solutions.
Program
- Welcome and investor lens
How investors assess an opportunity and what they need to understand early in the conversation. - The DOs and DON’Ts of an effective pitch deck
Structure, clarity, evidence, differentiation and the most common mistakes. - Communicating with clarity and conviction
Turning science, technology and market complexity into a focused and credible story. - Key takeaways and next steps
How to apply the learning before Session 2.
Key topics
- What investors are really listening for
- How to frame unmet need, solution, evidence and market opportunity
- How to adapt the narrative across medical biotech, medtech and digital health
- How to communicate development milestones, risks and the funding ask
- How to make the pitch memorable while remaining accurate and credible
Ready to join?
The program is open to all Biovia members and HealthTech Investor Summit participants. This first session will be online. *For future sessions: hybrid access is available for participants based outside Belgium.
We encourage you to follow the full series to build progressively from pitch to market strategy and financing.
More info on the other session from the Ready to Scale, Ready to Fund series:
- Session 2: Master your go-to-market and IP strategy (05 November 2026, Diegem - Hybrid*)
- Session 3: Corporate venturing and venture capital deep dive (17 November 2026, Antwerp - Hybrid*)
- Session 4: Funding beyond VCs (26 November 2026, Antwerp - Hybrid*)